{"id":"W1963879883","doi":"10.1111/j.1365-2141.2008.07353.x","title":"Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma","year":2008,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Rituximab; Lymphoma; Medicine; Cancer research; Oligonucleotide; Hodgkin lymphoma; Monoclonal; Internal medicine; Oncology; Monoclonal antibody; Immunology; Chemistry; Antibody; Biochemistry; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002021982,0.001441701,0.002763679,0.0004367112,0.0003395542,0.0007690983,0.0008309049,0.001069103,0.001727881],"category_scores_gemma":[0.001091929,0.0005899135,0.0008838805,0.0003924275,0.0009990333,0.000719855,0.0003743844,0.001868165,0.00058226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006961417,"about_ca_system_score_gemma":0.001038086,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009104586,"about_ca_topic_score_gemma":0.001733994,"domain_scores_codex":[0.9992173,0.0005096575,0.00003581261,0.0001011603,0.00005375197,0.00008232836],"domain_scores_gemma":[0.999325,0.0001262484,0.0001334643,0.00005047129,0.0000436616,0.0003210857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8209615,0.0482182,0.005744512,0.0006967259,0.001800794,0.0002609281,0.0004078678,0.001562517,0.03587919,0.0001832294,0.001555324,0.08272904],"study_design_scores_gemma":[0.6019359,0.388524,0.004964505,0.00001762323,0.000508457,0.0001466814,0.00005069257,0.000537854,0.001895385,0.00005073712,0.001352771,0.00001547932],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955285,0.001861217,0.0003597582,0.0002556273,0.00009945007,0.001070054,0.0001827507,0.00005985119,0.0005828025],"genre_scores_gemma":[0.9934056,0.00170194,0.001104911,0.0003823572,0.0002129632,0.001297944,0.0005542366,0.0000244651,0.001315639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002763679,"threshold_uncertainty_score":0.01069337,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01035893087214734,"score_gpt":0.2494229310716023,"score_spread":0.2390640001994549,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}